SCHEMBL5670575

SCHEMBL5670575

Cc1cc2c(cc1C)OC(C)C(N)=N2

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5671427 0.79 NOS3 (0.43) ESR1ESR2
SCHEMBL6993506 0.76 KDM4E (0.34) ESR1ESR2
SCHEMBL7985549 0.74 MAPT (0.43) ESR1ESR2
SCHEMBL7989336 0.74 MAPT (0.43) ESR1ESR2
Hydrochloric Acid SCHEMBL7980991 0.73 MAPT (0.42) ESR1ESR2
SCHEMBL7982265 0.71 NOS3 (0.33)
SCHEMBL7002022 0.70 NOS3 (0.43) ESR1ESR2
SCHEMBL7708358 0.70 ALDH1A1 (0.43)
SCHEMBL6611984 0.68 PARP1 (0.45)
SCHEMBL6991149 0.68 NOS3 (0.48) ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0980362-B1 SUBSTITUTED HETEROCYCLES AND THEIR USE IN MEDICAMENTS SCHERING AG (DE) 2006-08-16 EP disclosed
US-6191127-B1 ANTIINFLAMMATORY AGENTS, AUTOIMMUNE DISEASES, CARDIOVASCULAR DISORDERS, NERVOUS SYSTEM DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed
EP-0980362-A1 SUBSTITUTED HETEROCYCLES AND THEIR USE IN MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 2000-02-23 EP disclosed
WO-1998050372-A1 SUBSTITUTED HETEROCYCLES AND THEIR USE IN MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 1998-11-12 WO disclosed